Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
AssigneeIovance Biotherapeutics, Inc.
InventorsCecile Chartier-Courtaud, Krit Ritthipichai
Life of this patent
Estimating the term…
Loading patent…
AssigneeIovance Biotherapeutics, Inc.
InventorsCecile Chartier-Courtaud, Krit Ritthipichai
Estimating the term…
The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. The methods may comprise gene-editing at least a portion of the TILs to enhance their therapeutic efficacy. Such TILs find use in therapeutic treatment regimens.
(canceled)
A method for producing a therapeutic population of genetically modified tumor infiltrating lymphocytes (TILs), comprising:
Dependencies are inferred from the claim text.